Clinical Trial Update: Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

View source ↗

Summary

A registry study to evaluate cancer and aging resilience in older adults with hematologic malignancies, including multiple myeloma, amyloidosis, and plasma cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis
• Multiple Myeloma
• Plasma Cell Leukemia

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Multiple Myeloma, Amyloidosis | Status: RECRUITING